{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:18:35Z","timestamp":1791497915139,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011652","name":"Indian Institute of Science Education and Research Mohali","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011652","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5P30 CA036727-33"],"award-info":[{"award-number":["5P30 CA036727-33"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AI129745"],"award-info":[{"award-number":["R01-AI129745"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004541","name":"Ministry of Human Resource Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007116","name":"Indian Institute of Science Education and Research Pune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007116","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.cbi.2020.109282","type":"journal-article","created":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T22:48:30Z","timestamp":1601938110000},"page":"109282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19"],"prefix":"10.1016","volume":"331","author":[{"given":"Amjad","family":"Husain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddappa N.","family":"Byrareddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.cbi.2020.109282_bib1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.cbi.2020.109282_bib2","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nm.3595","article-title":"Overcoming drug development bottlenecks with repurposing: old drugs learn new tricks","volume":"20","author":"Strittmatter","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.cbi.2020.109282_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3389\/fonc.2017.00273","article-title":"Giving drugs a second chance: overcoming regulatory and financial hurdles in repurposing approved drugs as cancer therapeutics","volume":"7","author":"Hernandez","year":"2017","journal-title":"Front. Oncol."},{"issue":"19","key":"10.1016\/j.cbi.2020.109282_bib4","doi-asserted-by":"crossref","first-page":"8924","DOI":"10.1128\/JVI.01429-16","article-title":"Abelson kinase inhibitors are potent inhibitors of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus fusion","volume":"90","author":"Coleman","year":"2016","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.cbi.2020.109282_bib5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.00102-14","article-title":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease","volume":"28","author":"Chan","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.cbi.2020.109282_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-nutr-071714-034355","article-title":"The roles of mTOR complexes in lipid metabolism","volume":"35","author":"Caron","year":"2015","journal-title":"Annu. Rev. Nutr."},{"issue":"7","key":"10.1016\/j.cbi.2020.109282_bib7","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.tcb.2014.03.003","article-title":"Regulation of mTORC1 by amino acids","volume":"24","author":"Bar-Peled","year":"2014","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.cbi.2020.109282_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cell.2015.02.041","article-title":"Nutrient-sensing mechanisms across evolution","volume":"161","author":"Chantranupong","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cbi.2020.109282_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1139\/y77-007","article-title":"Inhibition of the immune response by rapamycin, a new antifungal antibiotic","volume":"55","author":"Martel","year":"1977","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.cbi.2020.109282_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4049\/jimmunol.144.1.251","article-title":"Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin","volume":"144","author":"Dumont","year":"1990","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cbi.2020.109282_bib11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1158\/2159-8290.CD-13-0929","article-title":"A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity","volume":"4","author":"Grabiner","year":"2014","journal-title":"Canc. Discov."},{"issue":"5","key":"10.1016\/j.cbi.2020.109282_bib12","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/2159-8290.CD-13-0353","article-title":"Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib","volume":"4","author":"Wagle","year":"2014","journal-title":"Canc. Discov."},{"issue":"18","key":"10.1016\/j.cbi.2020.109282_bib13","doi-asserted-by":"crossref","first-page":"10314","DOI":"10.1073\/pnas.171076798","article-title":"Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP\/mTOR","volume":"98","author":"Neshat","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.cbi.2020.109282_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1083\/jcb.jcb.200206108","article-title":"Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent","volume":"159","author":"Jaeschke","year":"2002","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.cbi.2020.109282_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2004.06.007","article-title":"The LKB1 tumor suppressor negatively regulates mTOR signaling","volume":"6","author":"Shaw","year":"2004","journal-title":"Canc. Cell"},{"issue":"24","key":"10.1016\/j.cbi.2020.109282_bib16","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1200\/JCO.2010.34.1578","article-title":"Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group","volume":"29","author":"Oza","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"7253","key":"10.1016\/j.cbi.2020.109282_bib17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice","volume":"460","author":"Harrison","year":"2009","journal-title":"Nature"},{"issue":"6967","key":"10.1016\/j.cbi.2020.109282_bib18","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/426620a","article-title":"Genetics: influence of TOR kinase on lifespan in C. elegans","volume":"426","author":"Vellai","year":"2003","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cbi.2020.109282_bib19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/acel.12203","article-title":"Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart","volume":"13","author":"Dai","year":"2014","journal-title":"Aging Cell"},{"issue":"18","key":"10.1016\/j.cbi.2020.109282_bib20","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.4161\/cc.5.18.3288","article-title":"Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition","volume":"5","author":"Blagosklonny","year":"2006","journal-title":"Cell Cycle"},{"issue":"5\u20136","key":"10.1016\/j.cbi.2020.109282_bib21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.drudis.2007.01.004","article-title":"An anti-aging drug today: from senescence-promoting genes to anti-aging pill","volume":"12","author":"Blagosklonny","year":"2007","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.cbi.2020.109282_bib22","first-page":"7","article-title":"Biology of healthy aging and longevity","volume":"68","author":"Carmona","year":"2016","journal-title":"Rev. Invest. Clin."},{"issue":"5","key":"10.1016\/j.cbi.2020.109282_bib23","first-page":"328","article-title":"Prolonged rapamycin treatment led to beneficial metabolic switch","volume":"5","author":"Fang","year":"2013","journal-title":"Aging (N Y)"},{"issue":"2","key":"10.1016\/j.cbi.2020.109282_bib24","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.ahj.2004.03.046","article-title":"Oral rapamycin to prevent human coronary stent restenosis: a pilot study","volume":"148","author":"Guarda","year":"2004","journal-title":"Am. Heart J."},{"issue":"12","key":"10.1016\/j.cbi.2020.109282_bib25","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000057979.36322.88","article-title":"Rapamycin attenuates load-induced cardiac hypertrophy in mice","volume":"107","author":"Shioi","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cbi.2020.109282_bib26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/cdd.2008.110","article-title":"Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies","volume":"16","author":"Sarkar","year":"2009","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.cbi.2020.109282_bib27","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ajpath.2012.04.018","article-title":"Prevention of age-related macular degeneration-like retinopathy by rapamycin in rats","volume":"181","author":"Kolosova","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.cbi.2020.109282_bib28","first-page":"314","article-title":"Rapamycin transiently induces mitochondrial remodeling to reprogram energy metabolism in old hearts","volume":"8","author":"Chiao","year":"2016","journal-title":"Aging (N Y)"},{"issue":"2","key":"10.1016\/j.cbi.2020.109282_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"169","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.cbi.2020.109282_bib30","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.cbi.2020.109282_bib31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S2213-8587(20)30183-2","article-title":"Vitamin-D and COVID-19: do deficient risk a poorer outcome?","volume":"8","author":"Mitchell","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"4","key":"10.1016\/j.cbi.2020.109282_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/nu12040988","article-title":"Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths","volume":"12","author":"Grant","year":"2020","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.cbi.2020.109282_bib33","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1210\/jc.2015-3555","article-title":"Vitamin D3 inhibits Wnt\/\u03b2-catenin and mTOR signaling pathways in human uterine fibroid cells","volume":"101","author":"Al-Hendy","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.cbi.2020.109282_bib34","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.4161\/cc.10.12.15620","article-title":"Vitamin D: a new player in the world of mTOR signaling","volume":"10","author":"Lisse","year":"2011","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.cbi.2020.109282_bib35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.fertnstert.2010.07.1041","article-title":"Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase","volume":"95","author":"Sharan","year":"2011","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.cbi.2020.109282_bib36","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1254\/jphs.08215FP","article-title":"Rapamycin protects against high fat diet-induced obesity in C57BL\/6J mice","volume":"109","author":"Chang","year":"2009","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.cbi.2020.109282_bib37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cca.2020.06.017","article-title":"Cytokine storm induced by SARS-CoV-2","volume":"509","author":"Song","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"11","key":"10.1016\/j.cbi.2020.109282_bib38","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.4049\/jimmunol.1203094","article-title":"Mammalian target of rapamycin regulates IL-10 and resistance to Pseudomonas aeruginosa corneal infection","volume":"190","author":"Foldenauer","year":"2013","journal-title":"J. Immunol."},{"issue":"15","key":"10.1016\/j.cbi.2020.109282_bib39","first-page":"4472","article-title":"Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas","volume":"63","author":"Nepomuceno","year":"2003","journal-title":"Canc. Res."},{"issue":"11","key":"10.1016\/j.cbi.2020.109282_bib40","first-page":"4822","article-title":"Rapamycin targets Interleukin 6 (IL-6) expression and suppresses endothelial cell invasion stimulated by tumor cells","volume":"8","author":"Ekshyyan","year":"2016","journal-title":"Am. J. Trans. Res."},{"issue":"4","key":"10.1016\/j.cbi.2020.109282_bib41","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1600-6143.2011.03473.x","article-title":"Paradoxical aspects of rapamycin immunobiology in transplantation","volume":"11","author":"Ferrer","year":"2011","journal-title":"Am. J. Transplant."},{"issue":"6","key":"10.1016\/j.cbi.2020.109282_bib42","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1111\/j.1600-6143.2012.04002.x","article-title":"CMV late phase-induced mTOR activation is essential for efficient virus replication in polarized human macrophages","volume":"12","author":"Poglitsch","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"6508","key":"10.1016\/j.cbi.2020.109282_bib43","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.abc6261","article-title":"Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans","volume":"369","author":"Arunachalam","year":"2020","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.cbi.2020.109282_bib44","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1093\/ndt\/gfm420","article-title":"Pneumonitis associated with sirolimus: clinical characteristics, risk factors and outcome--a single-centre experience and review of the literature","volume":"22","author":"Weiner","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.cbi.2020.109282_bib45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1517\/14740338.2013.752814","article-title":"Adverse events associated with mTOR inhibitors","volume":"12","author":"Pallet","year":"2013","journal-title":"Expet Opin. Drug Saf."},{"issue":"3","key":"10.1016\/j.cbi.2020.109282_bib46","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.trre.2014.03.002","article-title":"Strategies for the management of adverse events associated with mTOR inhibitors","volume":"28","author":"Kaplan","year":"2014","journal-title":"Transplant. Rev."},{"issue":"6","key":"10.1016\/j.cbi.2020.109282_bib47","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.cell.2012.07.032","article-title":"Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1","volume":"150","author":"Bar-Peled","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2020.109282_bib48","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.11058","article-title":"Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity","volume":"5","author":"Carroll","year":"2016","journal-title":"Elife"},{"issue":"12","key":"10.1016\/j.cbi.2020.109282_bib49","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41573-019-0036-1","article-title":"Lysosomes as a therapeutic target","volume":"18","author":"Bonam","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cbi.2020.109282_bib50","first-page":"21","article-title":"Oncogenic mutations of PIK3CA in human cancers","volume":"347","author":"Samuels","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"29","key":"10.1016\/j.cbi.2020.109282_bib51","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1038\/onc.2011.42","article-title":"PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs","volume":"30","author":"Weigelt","year":"2011","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.cbi.2020.109282_bib52","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1172\/JCI37539","article-title":"Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus","volume":"120","author":"Di Nicolantonio","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cbi.2020.109282_bib53","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3389\/fphys.2017.00788","article-title":"mTOR as a key regulator in maintaining skeletal muscle mass","volume":"8","author":"Yoon","year":"2017","journal-title":"Front. Physiol."},{"issue":"2","key":"10.1016\/j.cbi.2020.109282_bib54","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.canlet.2015.07.012","article-title":"Expression of angiogenic switch, cachexia and inflammation factors at the crossroad in undifferentiated thyroid carcinoma with BRAF(V600E)","volume":"380","author":"Husain","year":"2016","journal-title":"Canc. Lett."},{"issue":"8","key":"10.1016\/j.cbi.2020.109282_bib55","first-page":"6511","article-title":"COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?","volume":"12","author":"Sargiacomo","year":"2020","journal-title":"Aging (N Y)"},{"key":"10.1016\/j.cbi.2020.109282_bib56","first-page":"1","article-title":"An update on current therapeutic drugs treating COVID-19","author":"Wu","year":"2020","journal-title":"Curr. Pharmacol. Rep."},{"key":"10.1016\/j.cbi.2020.109282_bib57","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Discov."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000927972031053X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000927972031053X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:02:34Z","timestamp":1757858554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000927972031053X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":57,"alternative-id":["S000927972031053X"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2020.109282","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2020.109282","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109282"}}